Table 2.
Glomerular disease diagnoses.
| Men | Women | Total | |
|---|---|---|---|
| Isolated nondiabetic renal diseases | |||
| Membranous glomerulonephritis | 4 | 6 | 10 (30.3%, 95% CI 17.25%-47.46%) |
| IgA nephropathy | 4 | 4 | 8 (24.24%, 95% CI 12.60%-41.25%) |
| Lupus nephritis | — | 3 | 3 (9.09%, 95% CI 2.37%-24.34%) |
| Focal segmental glomerulosclerosis | 2 | 1 | 3 (9.09%, 95% CI 2.37%-24.34%) |
| Minimal change disease | — | 1 | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Benign nephrosclerosis/chronic tubulointerstitial nephritis | — | 1 | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Chronic tubulointerstitial nephritis | 1 | — | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Nondiabetic renal diseases associated with diabetic nephropathy | |||
| Nephropathy associated with HIV+diabetic nephropathy | — | 1 | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Diffuse proliferative glomerulonephritis+diabetic nephropathy | — | 1 | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Focal segmental glomerulosclerosis+diabetic nephropathy | — | 1 | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Glomerulonephritis associated with unclassified immune complexes+diabetic nephropathy | 1 | — | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Minimal change disease+diabetic nephropathy | 1 | — | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Postinfectious glomerulonephritis+diabetic nephropathy | 1 | — | 1 (3.03%, 95% CI 0.01%-16.65%) |
| Total | 14 | 19 | 33 |
95% CI: 95% confidence interval; HIV: human immunodeficiency virus.